These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 23771733

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased expression of ADAM12 and ADAM17 genes in laser-capture microdissected breast cancers and correlations with clinical and pathological characteristics.
    Narita D, Seclaman E, Ursoniu S, Anghel A.
    Acta Histochem; 2012 Feb; 114(2):131-9. PubMed ID: 21501859
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of ILK as a new partner of the ADAM12 disintegrin and metalloprotease in cell adhesion and survival.
    Leyme A, Bourd-Boittin K, Bonnier D, Falconer A, Arlot-Bonnemains Y, Théret N.
    Mol Biol Cell; 2012 Sep; 23(17):3461-72. PubMed ID: 22767580
    [Abstract] [Full Text] [Related]

  • 11. ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.
    Narita D, Seclaman E, Ilina R, Cireap N, Ursoniu S, Anghel A.
    Pathol Oncol Res; 2011 Jun; 17(2):375-85. PubMed ID: 21240579
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular profiling of ADAM12 and ADAM17 genes in human malignant melanoma.
    Cireap N, Narita D.
    Pathol Oncol Res; 2013 Oct; 19(4):755-62. PubMed ID: 23645517
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
    Duhachek-Muggy S, Zolkiewska A.
    BMC Cancer; 2015 Mar 04; 15():93. PubMed ID: 25886595
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.
    Cheon DJ, Li AJ, Beach JA, Walts AE, Tran H, Lester J, Karlan BY, Orsulic S.
    Carcinogenesis; 2015 Jul 04; 36(7):739-47. PubMed ID: 25926422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.